Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) has issued an announcement.
Race Oncology Ltd. has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting their commitment to transparency and accountability in management and oversight. This announcement reinforces Race Oncology’s dedication to maintaining high governance standards, potentially strengthening its position in the pharmaceutical industry and reassuring stakeholders of its robust management practices.
More about Race Oncology Ltd.
Race Oncology Ltd. operates in the pharmaceutical industry, focusing on developing and commercializing cancer therapies. The company is committed to advancing its pipeline of oncology drugs to address unmet medical needs in cancer treatment.
Average Trading Volume: 93,282
Technical Sentiment Signal: Sell
Current Market Cap: A$205M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.